Potential biomarkers include the alteration of signaling pathways in tumor cells, namely mutations in the interferon (IFN)-γ pathway, as well as pathways related to tumor cell proliferation and infiltration (Possick, 2017). The gene discussed is IFNG; the disease is neoplasm.